Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Conant Optical (2276 HKG): 1H26 Revenue and Margins Expand; XR Lenses Growth Story Slowly Unfolding

Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer

Shanghai Conant Optical (2276 HKG): Lens of Strong Fundamentals Makes the Growth Optics Visible

Conant Optical (2276 HKG): Growth Optics Sharp & Clear with Expanding Margins, Robust Sales in 1H25

Equity Bottom-Up

Shanghai Conant Optical / Equity Bottom-Up

<ul>
<li>In 2025, <a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (2276 HK)</a> reported revenue rise of 6% YoY to RMB 2.2M buoyed by growth of multifunctional lens (up 2%) and standardized lens (up 13%).</li>
<li>In 2025, the company kept up with its consistency of expanding its gross margins period after period, as margin expanded from 38.6% in 2024 to 42% in 2025.</li>
<li>Shanghai Conant’s robust demand outlook, capacity expansion plans, R&amp;D initiatives and margin strength offers a strong long term secular growth story.</li>
</ul>


In 2025, Shanghai Conant Optical (2276 HK) reported revenue rise of 6% YoY to RMB 2.2M buoyed by growth of multifunctional lens (up 2%) and standardized lens (up 13%).
In 2025, the company kept up with its consistency of expanding its gross margins period after period, as margin expanded from 38.6% in 2024 to 42% in 2025.
Shanghai Conant’s robust demand outlook, capacity expansion plans, R&amp;D initiatives and margin strength offers a strong long term secular growth story.


Conant Optical (2276 HKG): Revenue Rise, Margins Expand in 2025; XR Lenses To Pave Way For Future